Author

Huiling Mu

Nanjing University of Chinese Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Dongxin ZhaoiD· 1 shared Guanglei ZhuangiD· 1 shared Huaijiang XiangiD· 1 shared Jiajia LviD· 1 shared Kaiyan YeiD· 1 shared Li TaniD· 1 shared Libing XiangiD· 1 shared Lin ChengiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Dongxin ZhaoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting CDK12 condensates at nuclear speckles with rationally designed cyclin K molecular glue degraders

Kaiyan Ye, Qinyang He, Yan Cheng, Meiying Zhang, Huiling Mu, Mei‐Chun Cai, Shaoqing Zhou, Huaijiang Xiang, Yuqiao Hou, Yunxia Li, Yinuo Zang, Jiajia Lv, Lin Cheng, Libing Xiang, Dongxin Zhao, , Li Tan

This study identifies CDK12 condensates at nuclear speckles as a therapeutic target and demonstrates that cyclin K molecular glue degraders like HQY1428 disrupt these condensates, inhibiting oncogenic transcription and ovarian cancer growth.

bioRxiv · Mar 31, 2025 · PreprintCancer Biology